Increased uptake and new therapies needed to avert rising hepatitis C-related liver disease in England
11 June 2014
Hepatitis C (HCV) related disease in England is predicted to rise, and it is unclear whether treatment at current levels will be able to avert this.
If the infected population is left untreated, the number of patients with severe HCV-related disease will continue to increase and represent a substantial future burden on healthcare resources.
This can be mitigated by increasing treatment uptake, which will have the greatest impact if implemented quickly.
This study aims to estimate the number of people with chronic HCV infection in England that are treated and assess the impact and costs of increasing treatment uptake.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.